Director John Deane receives 11,670 Surgery Partners (SGRY) share grant

Rhea-AI Filing Summary

Deane John A reported acquisition or exercise transactions in this Form 4 filing.

Surgery Partners, Inc. director John A. Deane received a grant of 11,670 shares of Common Stock, valued at $13.71 per share, as equity compensation. These shares are scheduled to vest on June 5, 2027. Following this award, he directly holds 45,922 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Deane John A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,670	$13.71	$160K

Holdings After Transaction: Common Stock — 45,922 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 11,670 shares Grant value per share: $13.71 per share Total shares after transaction: 45,922 shares +1 more

4 metrics

Shares granted 11,670 shares Equity grant on June 5, 2026

Grant value per share $13.71 per share Common Stock grant price reference

Total shares after transaction 45,922 shares Direct holdings after grant

Vesting date June 5, 2027 Scheduled vesting of awarded shares

Key Terms

Grant, award, or other acquisition, Common Stock, vest

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest financial

"Shares will vest on June 5, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Deane John A

(Last) (First) (Middle)

C/O SURGERY PARTNERS, INC.

340 SEVEN SPRINGS WAY, SUITE 600

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Surgery Partners, Inc. [ SGRY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		11,670(1)	A	$13.71	45,922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest on June 5, 2027.

Remarks:

	/s/ Jennifer Baldock, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Surgery Partners (SGRY) director John A. Deane report on this Form 4?

Director John A. Deane reported receiving a grant of 11,670 shares of Common Stock as equity compensation. The filing shows this award at a value of $13.71 per share and updates his total direct holdings after the grant.

Is John A. Deane buying or selling Surgery Partners (SGRY) stock?

John A. Deane is not buying or selling in the open market. He reported an acquisition through a grant/award of 11,670 shares of Common Stock, a compensation-related transaction rather than a discretionary market trade.

When do the newly granted Surgery Partners (SGRY) shares vest for John A. Deane?

The newly granted shares are scheduled to vest on June 5, 2027. Vesting means Deane earns full rights to the shares over time, aligning his compensation with longer-term performance at Surgery Partners.

How many Surgery Partners (SGRY) shares does John A. Deane hold after this grant?

After the grant, John A. Deane directly holds 45,922 shares of Common Stock. This figure includes the newly awarded 11,670 shares and represents his updated direct ownership position reported in the Form 4 filing.

What does the Form 4 transaction code 'A' mean for Surgery Partners (SGRY)?

The Form 4 transaction code “A” indicates a grant, award, or other acquisition of securities. For Surgery Partners, this means John A. Deane received shares as compensation rather than through an open-market purchase.